The NASS Podcast

Featuring: Joseph H. Schwab, MD; Andrew J. Schoenfeld, MD

Disclosures:

Schoenfeld, Andrew J.: Royalties: Wolters Kluwer, Springer (B); Consulting: ArborMetrix (C); Trips/Travel: JBJS (A); Other Office: Journal of Bone and Joint Surgery (C); Research Support - Staff and/or Materials: CMS (D, Paid directly to institution/employer); Grants: Department of Defense (D, Paid directly to institution/employer), OREF (D, Paid directly to institution/employer), NIH (F, Paid directly to institution/employer).  

Schwab, Joseph H.: Scientific Advisory Board: Chordoma Foundation (Nonfinancial); Speaking and/or Teaching Arrangements: AO Spine (Travel Expense Reimbursement, Outside 12-Month Requirement), Stryker Spine (B, Outside 12-Month Requirement).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Featuring: Joseph H Schwab, MD; Dan M Sciubba, MD; Ilya Laufer, MD

Disclosures:

Schwab, Joseph H.: Scientific Advisory Board: Chordoma Foundation (None); Speaking and/or Teaching Arrangements: AOSpine (Travel Expense Reimbursement, Outside 12-Month Requirement), Stryker Spine (B, Outside 12-Month Requirement). 

Sciubba, Dan: Consulting: Baxter (B), DePuy Synthes (B), Globus (B), Medtronic (C), NuVasive (B), Stryker (C).  

Laufer, Ilya : Consulting: BrainLab (A), DePuy Synthes (B), Globus (B), Medtronic (C), SpineWave (B). 

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Featuring: F. Todd Wetzel, MD, John Ney, MD, Tara Stewart, PhD, DABNM

Disclosures:

Wetzel, F. Todd: Stock Ownership: Relievant Medical (1%). 

Ney, John: Board of Directors: American Society for Neuromonitoring (None); Consulting: Ceribell (B), SpecialtyCare (B); Other Office: American Academy of Neurology, Medical Economics and Management Committee (Travel Expense Reimbursement); Speaking and/or Teaching Arrangements: SpecialtyCare (Travel Expense Reimbursement). 

Stewart, Tara: Private Investments: IONM Life LLC (Future Compensation Expected, Paid directly to institution/employer)

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Featuring: Scott Blumenthal, MD, Richard D. Guyer, MD, Jack E. Zigler, MD

Disclosures:

Blumenthal, Scott: Royalties: Aesculap (A); Stock Ownership: FzioMed (1%), VertiFlex (1%), Centinel Spine (1%); Consulting: Sites Medical (None), Aesculap (C), Vertera (None), Bayliss Medical (C), Orthofix (None); Speaking and/or Teaching Arrangements: Aesculap (D), VertiFlex (B), Bayliss (None); Scientific Advisory Board: Aesculap (B), FzioMed (None), VertiFlex (B). 

Richard D. Guyer, MD: Royalties: Alphatec (B); Stock Ownership: Spinal Motion (None); Private Investments: Spinal Ventures I and II (5%); Consulting: DePuy/Synthes (B); Speaking and/or Teaching Arrangements: Synthes (None); Scientific Advisory Board: K2M (B), Spinal Kinetics (Stock options), Nanovis (Stock options), Crocker Technologies (None), MiMedx (None); Fellowship Support: NuVasive (D, Paid directly to institution/employer). 

Jack E. Zigler, MD: Consulting: Aesculap (C), Centinel Spine (C), FloSpine (B), Medtronic Spine (B), Orthofix (B), Simplify Medical (B); Royalties: Zimmer Spine (B); Scientific Advisory Board: Safe Orthopedics (Future Compensation Expected).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Featuring: F. Todd Wetzel, MD, Chris J. Main, MA, PhD, Gregory L. Whitcomb, DC

Disclosures:

Wetzel, F. Todd: Stock Ownership: Relievant Medical (1%). 

Main, Chris J.: Consulting: Medrisk Inc International Scientific Advisory Board (B, Paid directly to institution/employer); Device or Biologic Distribution Group (Physician-Owned Distributorship): The Back Book (B). 

Whitcomb, Gregory L.: Speaking and/or Teaching Arrangements: North American Spine Society (B); Trips/Travel: North American Spine Society (B).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Featuring: Scott Blumenthal, MD, Richard D. Guyer, MD, Jack E. Zigler, MD

Disclosures:

Blumenthal, Scott: Royalties: Aesculap (A); Stock Ownership: FzioMed (1%), VertiFlex (1%), Centinel Spine (1%); Consulting: Sites Medical (None), Aesculap (C), Vertera (None), Bayliss Medical (C), Orthofix (None); Speaking and/or Teaching Arrangements: Aesculap (D), VertiFlex (B), Bayliss (None); Scientific Advisory Board: Aesculap (B), FzioMed (None), VertiFlex (B). 

Guyer, Richard D.: Royalties: Alphatec (B); Stock Ownership: Spinal Motion (None); Private Investments: Spinal Ventures I and II (5%); Consulting: DePuy/Synthes (B); Speaking and/or Teaching Arrangements: Synthes (None); Scientific Advisory Board: K2M (B), Spinal Kinetics (Stock options), Nanovis (Stock options), Crocker Technologies (None), MiMedx (None); Fellowship Support: NuVasive (D, Paid directly to institution/employer). 

Zigler, Jack E.: Consulting: Aesculap (C), Centinel Spine (C), FloSpine (B), Medtronic Spine (B), Orthofix (B), Simplify Medical (B); Royalties: Zimmer Spine (B); Scientific Advisory Board: Safe Orthopedics (Future Compensation Expected).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

[12 of 12]

Section on Intraoperative Neurophysiological Monitoring (IONM) Section Co-Chairs Dr. Rich Vogel and Dr. Adam Doan discuss the question, “Are wakeups always prolonged with neuromonitoring under TIVA?”

It’s a common complaint: we use TIVA for MEPs, but the patients take forever to wake up from anesthesia. To combat this problem, many surgeons elect to discontinue IONM earlier in the procedure. Did you know IONM has the technology to guide the anesthesia team through a faster wakeup in most cases? It requires communication and collaboration, but it’s easy to do. Here we review these techniques.

Disclosures:

Doan, Adam: Private Investments (including venture capital, start-ups): Veridical RCM, LLC (D).

Vogel, Richard: Board of Directors: American Board Of Neurophysiologic Monitoring (Nonfinancial, Examiner for Board), American Society Of Neurophysiological Monitoring (Nonfinancial, President of the Society (2019-2020)); Consulting: Medicolegal Expert Witness Consulting (D); Other: NuVasive (Salary); Speaking and/or Teaching Arrangements: Neurophysiology Services Australia (None); Trips/Travel: North American Spine Society (Travel Expense Reimbursement), University Of Sydney (Travel Expense Reimbursement).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

[3 of 3]

In this newest episode from the Section on Spine Oncology , Drs. Schwab, Sciubba, and Goodwin discuss operating on neurofibromas. 

Surgery on patients with neurofibromas can range from relatively straightforward (simple neurofibromas) to life-threatening (complex plexiform neurofibromas).  In patients with plexiform neurofibromas, particularly those near the spinal cord, care needs to be taken preoperatively, when considering surgical indications, as well as intra-operatively, where hemostasis can become challenging.  

Disclosures:

Goodwin, Matthew L.: Consulting: Augmedics (A); Fellowship Support: AO Spine  (Salary, Fellowship Support), NREF (Salary, Fellowship Support); Royalties: Kendall Hunt (B); Stock Ownership: ROM3 (200 Shares, Outside 12-Month Requirement).

Schwab, Joseph H.: Scientific Advisory Board: Chordoma Foundation (None); Speaking and/or Teaching Arrangements: AO Spine (Travel Expense Reimbursement, Outside 12-Month Requirement),  Stryker Spine (B, Outside 12-Month Requirement).

Sciubba, Daniel M.: Consulting: Baxter (B), DePuy Synthes (B), Globus (B), Medtronic (C), NuVasive (B), Stryker (C).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

[11 of 12]

Section on Intraoperative Neurophysiological Monitoring (IONM) Section Co-Chairs Dr. Rich Vogel and Dr. Adam Doan discuss the question, “Neuromonitoring lost their signals, now what?”

Aside from checking wires and anesthesia, what else works? It turns out there is a lot one can do to restore signals. Here the Co-Chairs review these checks and interventions.

Disclosures:

Doan, Adam: Private Investments (including venture capital, start-ups): Veridical RCM, LLC (D).

Vogel, Richard: Board of Directors: American Board Of Neurophysiologic Monitoring (Nonfinancial, Examiner for Board), American Society Of Neurophysiological Monitoring (Nonfinancial, President of the Society (2019-2020)); Consulting: Medicolegal Expert Witness Consulting (D); Other: NuVasive (Salary); Speaking and/or Teaching Arrangements: Neurophysiology Services Australia (None); Trips/Travel: North American Spine Society (Travel Expense Reimbursement), University Of Sydney (Travel Expense Reimbursement).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

[10 of 12]

Section on Intraoperative Neurophysiological Monitoring (IONM) Section Co-Chairs Dr. Rich Vogel and Dr. Adam Doan discuss, "Diagnostic accuracy of IONM from the neurophysiologist’s perspective."

They review the traditional diagnostic table (i.e., ± alert, ± deficit) and consider other factors like intervention, resolution of data, type of monitoring modality, etc. They also present an advanced diagnostic table that is inclusive of these factors. This has major implications for developing and interpreting research.

Disclosures:

Doan, Adam: Private Investments (including venture capital, start-ups): Veridical RCM, LLC (D).

Vogel, Richard: Board of Directors: American Board Of Neurophysiologic Monitoring (Nonfinancial, Examiner for Board), American Society Of Neurophysiological Monitoring (Nonfinancial, President of the Society (2019-2020)); Consulting: Medicolegal Expert Witness Consulting (D); Other: NuVasive (Salary); Speaking and/or Teaching Arrangements: Neurophysiology Services Australia (None); Trips/Travel: North American Spine Society (Travel Expense Reimbursement), University Of Sydney (Travel Expense Reimbursement).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+